CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Shares withheld for taxes See Remarks gave up 78,134 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 221,500 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 144,284 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 177,200 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 41,318 shares (to pay taxes)
- 8-K Event Results of operations
- 4 Shares withheld for taxes See Remarks gave up 39,443 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 24,501 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 12,401 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 32,059 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 32,039 shares (to pay taxes)
- 4 Option exercise See Remarks acquired 19,483 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 4,515 shares at $2.25 ($10,147)
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 4,285 shares at $2.37 ($10,134)
Page 8 of 18 · 346 filings